MeadWestvaco (MWV) has released the results of a study that the company commissioned on packaging damage. Results revealed that damaged packaging has a profound effect on shoppers’ purchasing
Amunix and Versartis have reported that the scientific journal Nature Biotechnology has published a comprehensive paper entitled ‘A recombinant polypeptide extends the in vivo half-life of peptides and
Abbott has reported results from the ARBITER 6 – HALTS study showed patients at high cardiovascular risk had significant regression of atherosclerosis after 8 and 14 months of
Sinovac Biotech has reported that it was selected by the Shanghai government to supply its inactivated hepatitis A vaccine, Healive, in Shanghai. Out of the five vaccine manufacturers
PanGenetics, developing PG110, a humanised antibody to Nerve Growth Factor (NGF), has entered into an agreement with Abbott. Under the agreement Abbott will acquire the global rights to
Merck & Co. has expressed its confidence in the safety and efficacy profiles of Zetia (ezetimibe) and Vytorin (ezetimibe/simvastatin). The results of ARBITER 6 were widely predicted because
Bristol-Myers Squibb has announced that it will split off its holdings in Mead Johnson Nutrition. The company expects the split-off to be a tax-advantaged way to further deliver
The Medicines Company announced that the data from 13,941 patients treated in the discontinued CHAMPION Phase III program of cangrelor. CHAMPION program data were analysed after the program’s
Glenmark Generics (GGL) has received ANDA approval from the FDA for Ciclopirox Olamine cream, 0.77 % and will commence marketing and distribution of the product in the US
Chadha is president of Balcorp Limited, an international trade and marketing firm, which he founded in 1976 and built into a successful company with about $100 million in
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.